JP Morgan Chase’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-535,498
| Closed | -$10.1M | – | 6096 |
|
|
2019
Q3 | $10.1M | Buy |
535,498
+304,759
| +132% | +$3.49M | ﹤0.01% | 2134 |
|
|
2019
Q2 | $2.61M | Sell |
230,739
-9,828
| -4% | -$119K | ﹤0.01% | 3198 |
|
|
2019
Q1 | $3.28M | Sell |
240,567
-15,573
| -6% | -$202K | ﹤0.01% | 2949 |
|
|
2018
Q4 | $2.63M | Sell |
256,140
-14,232
| -5% | -$182K | ﹤0.01% | 3091 |
|
|
2018
Q3 | $4.5M | Sell |
270,372
-26,065
| -9% | -$471K | ﹤0.01% | 2823 |
|
|
2018
Q2 | $4.68M | Sell |
296,437
-53,204
| -15% | -$808K | ﹤0.01% | 2736 |
|
|
2018
Q1 | $4.44M | Sell |
349,641
-70,964
| -17% | -$1.03M | ﹤0.01% | 2678 |
|
|
2017
Q4 | $4.82M | Buy |
420,605
+905
| +0.2% | +$10.1K | ﹤0.01% | 2710 |
|
|
2017
Q3 | $4.81M | Buy |
419,700
+184,097
| +78% | +$1.92M | ﹤0.01% | 2590 |
|
|
2017
Q2 | $2.7M | Buy |
235,603
+228,205
| +3,085% | +$4.22M | ﹤0.01% | 2869 |
|
|
2017
Q1 | $155K | Sell |
7,398
-45,956
| -86% | -$1.02M | ﹤0.01% | 4182 |
|
|
2016
Q4 | $1.11M | Buy |
53,354
+52,402
| +5,504% | +$1.36M | ﹤0.01% | 3392 |
|
|
2016
Q3 | $31K | Sell |
952
-344,869
| -100% | -$10.5M | ﹤0.01% | 4117 |
|
|
2016
Q2 | $8.64M | Sell |
345,821
-3,661
| -1% | -$99K | ﹤0.01% | 1937 |
|
|
2016
Q1 | $8.56M | Buy |
349,482
+35,883
| +11% | +$831K | ﹤0.01% | 1864 |
|
|
2015
Q4 | $10.4M | Buy |
313,599
+89,681
| +40% | +$3.03M | ﹤0.01% | 1798 |
|
|
2015
Q3 | $7.33M | Buy |
+223,918
| New | +$9.52M | ﹤0.01% | 1978 |
|